SignatureFD’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

SignatureFD’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-68	Closed	-$2.61K	–	3363
2023 Q2	$2.61K	Buy	68 +25	+58%	+$642	﹤0.01%	2726
2023 Q1	$995	Buy	+43	New	+$1.02K	﹤0.01%	2996
2022 Q3	–	Sell	-67	Closed	-$1K	–	3426
2022 Q2	$1K	Buy	+67	New	+$1.05K	﹤0.01%	3060

SignatureFD's KDNY Position: Q3 2023 in Review

SignatureFD sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 68 shares — an estimated $2.61K sold.

SignatureFD first reported a position in KDNY in Q2 2022 and held it in 3 quarters. The position peaked at $2.61K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

SignatureFD reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
SignatureFD sold 68 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.61K.
SignatureFD first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
SignatureFD's Chinook Therapeutics, Inc. Common Stock position peaked at $2.61K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on SignatureFD's 13F filing for Q3 2023, filed 3 Nov 2023.